ARTICLE | Clinical News
ASC-101 regulatory update
April 4, 2011 7:00 AM UTC
FDA granted Orphan Drug designation for America Stem Cell's ASC-101 to treat myeloablation in patients receiving hematopoietic stem cell transplantation. The human recombinant enzyme is in preclinical...